Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05095181
NCT05095181
Completed
Not Applicable

Preventive and Personalized Medicine (2021-2023)

Asfendiyarov Kazakh National Medical University1 site in 1 country1,000 target enrollmentMarch 29, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsLiver Cirrhosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Cirrhosis
Sponsor
Asfendiyarov Kazakh National Medical University
Enrollment
1000
Locations
1
Primary Endpoint
genotyping for the SNP associated with liver cirrhosis
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to identify genetic determinants of susceptibility to liver cirrhosis . It will assist in predicting individual risks of disease progression and would help to clarify pathophysiologic mechanisms of liver cirrhosis .

Registry
clinicaltrials.gov
Start Date
March 29, 2021
End Date
January 20, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Asfendiyarov Kazakh National Medical University
Responsible Party
Principal Investigator
Principal Investigator

Ildar Fakhradiyev

Head of the Laboratory of Experimental Medicine

Asfendiyarov Kazakh National Medical University

Eligibility Criteria

Inclusion Criteria

  • •hepatitis B

Exclusion Criteria

  • •the casual aget of liver disease is not viral infection, such as alcohol abuse

Outcomes

Primary Outcomes

genotyping for the SNP associated with liver cirrhosis

Time Frame: 1 year

Genotype frequency of SNP in the study genes of participants and control participants.

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)Liver Cirrhosis
NCT00709085National Taiwan University Hospital320
Not yet recruiting
Not Applicable
Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic AnemiaHemolytic Anemia, ChronicLiver Diseases
NCT06743854Assiut University58
Completed
Not Applicable
Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLDHealthy
NCT04494360Janssen Research & Development, LLC830
Not yet recruiting
Not Applicable
Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver DiseaseDiagnosis ， Treatment， Genetic and Metabolic Liver Disease
NCT05601557Sujun Zheng480
Completed
Not Applicable
Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)Primary Biliary Cirrhosis
NCT01161953Mayo Clinic1,500